Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are the 'second generation' oral hypoglycemic agents really different?

E F Pfeiffer

    Acta Diabetologica Latina
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Self-monitoring of blood glucose compared with continuous tissue glucose measurement.

    Diabetes care·1997
    Same author

    Statistical approach for evolutionary relationship of alpha-conotoxins and members of insulin-superfamily.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1996
    Same author

    Does fall in tissue glucose precede fall in blood glucose?

    Diabetologia·1996
    Same author

    [Glucose sensors in tissue, glucose monitoring and controlled insulin administration].

    Medizinische Klinik (Munich, Germany : 1983)·1996
    Same author

    Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring.

    Diabetes care·1995
    Same author

    Quality control of intensified insulin therapy: HbA1 versus blood glucose.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1994
    Same journal

    Serum lipids, microalbuminuria and metabolic control in diabetic children.

    Acta diabetologica latina·1991
    Same journal

    Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus.

    Acta diabetologica latina·1991
    Same journal

    The effects of bilio-jejunal diversion on streptozotocin diabetes in the rat.

    Acta diabetologica latina·1991
    Same journal

    Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.

    Acta diabetologica latina·1991
    Same journal

    Anthropometric studies in diabetes in the Tropics.

    Acta diabetologica latina·1991
    Same journal

    Insulin requirement of simple and complex carbohydrate foods in type 1 (insulin-dependent) CSII-treated diabetic subjects, obtained by biostator. Correlation with glycaemic index.

    Acta diabetologica latina·1991
    See all related articles

    Second-generation sulfonylureas like glibenclamide enhance insulin release and offer new treatment options for diabetic patients. A specific glibenclamide-glucose test predicts oral antidiabetic therapy success.

    Area of Science:

    • Endocrinology
    • Pharmacology

    Background:

    • Sulfonylureas are a class of oral antidiabetic drugs that stimulate insulin release.
    • Existing sulfonylureas exhibit varying potencies and mechanisms of action.

    Observation:

    • Biochemical data suggest newer sulfonylureas, such as glibenclamide, interact with different B-cell sites than older drugs like tolbutamide.
    • Glibenclamide acts more as a potentiator of insulin release rather than a direct stimulator.

    Findings:

    • Second-generation sulfonylureas, exemplified by glibenclamide, demonstrate distinct pharmacological profiles.
    • These drugs exhibit extra-pancreatic effects, including somatostatin stimulation and glucagon inhibition, complementing their glucose-lowering actions.
    • A novel glibenclamide-glucose-response test aids in predicting patient response to oral antidiabetic therapy.

    Related Experiment Videos

    Implications:

    • Glibenclamide and similar drugs offer improved therapeutic options, potentially enabling successful treatment for patients previously unresponsive to sulfonylureas.
    • The glibenclamide-glucose-response test provides a valuable tool for personalized medicine in diabetes management.
    • Understanding the nuanced mechanisms of sulfonylureas can guide the development of more effective antidiabetic agents.